Chinese Herbal Medicines 在线投稿

期刊简介：《中草药（英文版）》（Chinese Herbal Medicines）（季刊）创刊于2009年，由天津药物研究院主管，天津药物研究院、中国医学科学院药用植物研究所主办，其中天津药物研究院为主要主办单位。办刊宗旨及业务范围为：继承和发扬祖国医药学遗产，报道和反映中草药研究最新进展，宣扬我国中草药传统特色，加强与世界各国传统药物研究的经验交流，在中医与西医、传统与现代、东方与西方之间架起一座理解好沟通的桥梁，促进中药现代化、国际化。主要栏目：临床论著、实验研究、经验交流、学术动态、研究进展、人物介绍、实用验方、综述。

投稿指南：《中草药（英文版）》作者须知Instruction for Authors 【官网信息】 Chinese Herbal Medicines (CHM) is an official international journal sponsored by Tianjin Institute of Pharmaceutical Research and Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences. The purpose of CHM is to provide a forum for the studies on Chinese herbal medicines, phytomedicines, and natural products as well. The journal will accept the following contributions: letters, original articles, review papers, short communications, book reviews, conference announcements, information, etc. The journal involves the studies on active ingredients and complex formulations of herbal medicines in medicinal resource, phytochemistry, pharmacology, toxicology, pharmacokinetics, and therapeutic function by experiment and clinical trials. It is the interest of this journal to introduce the latest development in pharmaceutical sciences to readers. The journal is included in the following databases: ESCI, PubMed Central, Scopus, DOAJ, CAB ABSTRACTS, CAS, EMBASE, IC, UPD, Global Health, etc. Since 2013, CHM has been selected as one of the Chinese Core Periodicals of Science and Technology for nine consecutive years. In 2019, CHM was successfully selected by China Association for Science and Technology for the China Science and Technology Journal Excellence Action Plan. The journal has been awarded the distinction of Excellent International Impact Academic Journals of China in 2016, 2019, 2020, 2021 and 2022. 1. Submission of manuscripts Authors could submit their manuscripts through online submission http://mc03.manuscriptcentral.com/chm. The following should be complied with: size of character 12 point, double-spaced, consecutive numbering of the lines and pages. The text should be in Word document for Windows. 2. Structure of manuscripts 2.1 Title Please provide a title that is concise, informative, and relevant, ideally it should contain no more than 30 words. 2.2 Authors and affiliation Please clearly indicate the given name(s) and family name(s) of each author and check that all names are accurately spelled. Capitalize the first letter in the surname(s) and spell out the given name(s) in full-name form. The corresponding author should be indicated by an asterisk (*) to the right of the name and the e-mail address given in the footnote. The affiliation of each author should be provided, including complete address information (city, zip code, and country). Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Any change in authorship must be approved in writing by all authors. Authors who have contributed equally should be marked with a superscript symbol (1). The following statement added in the footnote: “These authors contributed equally to this work”. The equal roles of authors should also be adequately disclosed in the authors’ contributions statement. 2.3 Abstract The paper should contain an abstract with 200–300 words in English. The abstract should summarize the main points of the article. The structure form of the abstract should consist of Objective (purpose of the study), Methods (basic procedures), Results (final findings with main data), and Conclusion (potential possibility on the result). …… 更多详情： https://www.tiprpress.com/chmen/site/menu/20100204181305001

投稿方式：在线投稿

联系方式：地址：天津市滨海高新区惠仁道306号 邮编：300462 电话：022-23006901（刊内；天津编辑部）；010-57833035（官网；北京编辑部） 传真：022-23006821（天津）；010-57833035（北京） 刊内微信公众号：中草药英文版CHM 刊内邮箱（202401期）：chm@tiprpress.com 刊内邮箱（202401期）：chmtianjin@126.com 刊内邮箱（202401期）：bjchm@tiprpress.com 刊内邮箱（202401期）：bjchmimplad@126.com

定价：40.00

期刊官网